Transitions in PAH Therapy is organized by Washington University School of Medicine in St. Louis.
Publication Date: Jul 1, 2020
Expiration Date: Jun 30, 2021
This course is designed for pulmonologists, intensivists, cardiologists, rheumatologists, internists, critical care physicians, primary care, nurses, nurse practitioners, physician assistants, pharmacists and other health professionals.
American Medical Association (AMA Credit):
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™.
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
• Summarize indications for transitioning between therapies for PAH.
• Determine the need to "step-up" therapy for patients not meeting comprehensive treatment goals.
• Appreciate unique pharmacologic aspects different prostacyclin pathway activators.
• Apply pre-transition criteria for safely "stepping down" in therapy.
• Describe how to determine success after transition.
Additional details will be posted as soon as information is available.
Cardiology, Pulmonary Medicine